CATEGORY RISK SCAN
Before you fund the fix, make sure you have the right problem.
Something in the commercial system is not working, and the company is about to spend more on it.
The Scan establishes whether the problem you can see is the problem that governs, before more execution and capital go behind the answer.
For investors and boards
One live situation. One bounded test. One decision.
You already have a diagnosis. Before capital, hiring capacity or management attention goes behind the response, test whether that diagnosis has ruled out a material market-frame cause.
- Maximum two weeks.
- Existing evidence first.
- No presumption that Category Risk exists.
Frame holds
The current diagnosis survives scrutiny.
The market frame is sufficiently coherent for the decision in front of leadership. The comparison set is intentional enough. The commercial entry point is not quietly redefining the company.
Proceed. Fix execution. Venturoxx leaves.
Frame unresolved
A material market-frame decision remains open.
Different parts of the organisation may be teaching materially different interpretations. The comparison set may be forming by default. A successful commercial entry point may be becoming the company definition without an explicit decision.
Leadership settles it first. Then move.
The Scan earns its place when a commitment is close.
Not every company needs this, and not at every moment.
It becomes worth doing when something consequential is about to be approved: a material increase in GTM spend, a senior commercial hire, a new market, a major partner motion, or another round of capital behind the current plan.
At that point one question has a real cost attached to it.
If nobody can answer that with confidence, the next commitment is being made partly in the dark.
Two days in a room with the leadership team is a different exercise.
Putting the CRO, CMO, product lead and board around a table is a reasonable instinct and often produces something useful. It is a different exercise, because everyone in that room holds a legitimate functional perspective with a real accountability attached to it, and the company-level decision is which of those accurate views should govern the others.
The Scan is a bounded external checkpoint. Internal teams bring the evidence from the work they own. Venturoxx tests those views against one company-level decision, without holding a functional position in the outcome.
It is not a facilitated session, an offsite or a workshop. Leadership is not being helped to run its own conversation.
Three answers, in order.
- 01
Where the problem actually sits
Whether the constraint is execution, the go-to-market system, or the market frame the company is being read through.
- 02
Which decisions belong to leadership
Evidence can settle a great deal. It cannot settle what the company should ask the market to understand first, or which comparison it should encourage. Those are decisions, and they are not delegable downwards.
- 03
What the market should be asked to prove next
An explicit direction, and the evidence that would show it is wrong.
Leadership finishes with those three answers written down and agreed, in a form the people accountable for execution can work from.
Maximum two weeks. Existing evidence first. Your team stays in the market.
The work starts with what the company already has: market language, sales conversations, buyer objections, partner translation, competitive comparison, investor material and how leadership currently explains the company. Most of that exists already. It is rarely read together.
Leadership is involved where judgement is genuinely required, not as a standing commitment. There is no discovery phase to staff and no request to pause execution.
That is the duration of the diagnosis. It is not a claim that the frame is perfected, that the market has been validated, or that any commercial result has been produced inside it.
The Scan ends in a decision, including the decision to stop.
For an investor entering through a live portfolio decision, the first question ends in frame holds or frame unresolved.
The full Scan below goes further: it also tests whether specific strategic claims or bets are supported by the evidence.
The frame holds
The market reads the company broadly as leadership intends. The constraint is execution or the go-to-market system, and it should be addressed as such. That is a useful answer and it is frequently the right one.
The frame is unresolved
Several credible interpretations are live at once and execution is beginning to settle the question by repetition. Leadership has decisions to take before more capital goes behind the current answer.
The bet is not supported
The evidence does not carry the strategic claim being made. Category work cannot manufacture proof that is not there, and more execution would increase exposure rather than reduce it.
Any of the three is a legitimate result. The Scan is not designed to produce a reason for more Venturoxx work.
What can be established here, and what only the market can settle.
The Scan can establish what leadership has decided, why, and what evidence would challenge it. It cannot establish that buyers will accept the frame or that commercial performance will change.
A reference case recording exactly that (the diagnosis, the decisions leadership took, and where the proof stops) is available on request.
An independent starting point, not the first stage of something larger.
The Scan is for leadership that is not yet certain what the governing problem is. Companies that already know their underlying system is unresolved need one governed architecture, which is the Blueprint. Companies with an agreed frame that needs to hold under pressure need Category Control.
Three starting points. No sequence, and no ladder.
The value is the decision, not the volume of work behind it.
Venturoxx does deep analysis. The buyer should not have to carry it. This is not a research programme, a messaging review, a positioning audit or a category workshop. None of those begins by asking whether the problem in front of you is the real one.
Scope and terms are agreed privately once fit is established.
CATEGORY RISK SCAN
Before you fund the response, find out what you are funding.
If a consequential commitment is approaching and the market interpretation behind it has not been deliberately settled, that is the moment worth two weeks.
If it has been settled, you will know that too.
Find the real problem. Make the decision. Move.